Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
JMIR Research Protocols|July 17, 2020
Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar: Protocol for a Feasibility StudyBridget Louise Draper, Alisa Pedrana, Jessica Howell, et al.
Viruses|November 24, 2022
Exploring the Public Health and Social Implications of Future Curative Hepatitis B InterventionsJack Wallace, Jacqueline Richmond, Jessica Howell, et al.
Hepatology, Medicine and Policy|October 6, 2018
"B in IT" - a community-based model for the management of hepatitis B patients in primary care clinics using a novel web-based clinical toolDebra A O'Leary, Eleanor Cropp, David Isaac, et al.
The International Journal on Drug Policy|December 24, 2019
A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatmentAnna Y Palmer, Amanda J Wade, Bridget Draper, et al.
JHEP Reports : Innovation in Hepatology|March 14, 2026
Very Low Energy Ketogenic Diet vs Mediterranean Diet for MASLD: Superior Steatosis Reduction in a Randomised Pilot StudyAnn M Farrell, Tonya Paris, Evelyn B Parr, et al.
The Medical Journal of Australia|May 20, 2019
Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statementJoseph Doyle, Michelle Raggatt, Monica Slavin, et al.
The International Journal on Drug Policy|May 27, 2019
Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility studyBridget Williams, Jessica Howell, Joseph Doyle, et al.
Oncotarget|February 18, 2017
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenibJessica Howell, David J Pinato, Ramya Ramaswami, et al.
Therapeutic Advances in Gastroenterology|October 6, 2022
Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort studyJessica Howell, Amit Samani, Binish Mannan, et al.
The International Journal on Drug Policy|May 1, 2022
Hepatitis C antibody testing among opioid agonist therapy recipients, Victoria, Australia, 2012 to 2020Joshua Dawe, Anna L Wilkinson, Jason Asselin, et al.
Pageof 8